Nutanix Inc <NTNX.O>: JP Morgan raises target price to $60 from $50
NTNX•Related News
ManpowerGroup returns to profit in Q2 FY26; revenue rises 8% to $4.9 billion
MAN•
Moderna doses first patient in Phase 1 trial of mRNA-4200 cancer therapy in solid tumors
MRNA•
Insmed reports positive 12-month TPIP extension data in pulmonary arterial hypertension study
INSM•
State Street Q2 EPS USD 3.65
STT•
PNC Financial Services <PNC.N>: Truist Securities Raises Target Price to $264 From $257
PNC•